Celemics, Inc.
- Home
- Companies
- Celemics, Inc.
- Products
- Celemics - Model CES - G-Mendeliome ...
Celemics - Model CES - G-Mendeliome Clinical Exome Sequencing Panel
FromCelemics, Inc.
Celemics’ G-Mendeliome Clinical Exome Sequencing (CES) Panel is designed to overcome the limitations of analyzing clinical diseases with conventional whole-exome sequencing.
Most popular related searches
The CES is a widely used diagnostic method to rapidly and efficiently detect disease-causing genetic variations within target genes in the human genome. The G-Mendeliome CES Panel includes both clinically significant genes used in other panels and other additional genes, therefore allowing customers to obtain comprehensive information of mutations in genes of interest in a cost-effective manner.
Comprehensive genomic profiling of a variety of genetic diseases
- Includes 7,000 genes associated with clinically significant genetic diseases
A wide range of target regions
- Includes all clinically significant regions that are not covered by competitor`s panels
Cost-effective analysis
- Able to provide accurate analysis with reduced sequencing costs compared to WES